Iliad Research & Trading, L.P. Reports 9.6% Passive Stake In Jaguar Health
Portfolio Pulse from Bill Haddad
Iliad Research & Trading, L.P. has reported a 9.6% passive stake in Jaguar Health, a pharmaceutical company.

December 29, 2023 | 4:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Iliad Research & Trading's 9.6% passive stake in Jaguar Health indicates a significant investment by an institutional investor.
The acquisition of a passive stake by Iliad Research & Trading suggests confidence in Jaguar Health's prospects, which could be viewed positively by the market. This type of investment often leads to increased investor interest and can be a bullish signal for the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100